Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 5;19(6):e0300191.
doi: 10.1371/journal.pone.0300191. eCollection 2024.

Prevalence, under-reporting, and epidemiological surveillance of COVID-19 in the Araguaína City of Brazil

Affiliations

Prevalence, under-reporting, and epidemiological surveillance of COVID-19 in the Araguaína City of Brazil

Monike da Silva Oliveira et al. PLoS One. .

Abstract

Asymptomatic and underreported individuals remain a source of coronafig disease 2019 (COVID-19) transmission to others. Data on the prevalence and epidemiological factors influencing transmission are fundamental for establishing control measures, especially in vulnerable regions such as the Amazon. This study aimed to determine the point prevalence and active infection of COVID-19 among the population in Araguaína, a Brazilian city located in the Amazon region, analyzed the socioeconomic and behavioral variables of a statistically representative sample of this population using an epidemiological survey, and identify the viral genomic diversity in the region. During the sixth epidemiological week of 2021 (February 8 to 12), samples of 497 inhabitants of the municipality asymptomatic for respiratory syndromes underwent reverse transcription-quantitative polymerase chain reaction and serological tests (immunoglobulin M and immunoglobulin G). A questionnaire collated data on socioeconomic factors, prevention measures, and health status history. The active infection rate was 6.2%, and the prevalence was 13.5% of the study population. Active infection cases were under-reported; each reported positive case represented 14-28 under-reported cases. Lineages P.2, P.1, and B.1.1 were detected. Working from home was a protective factor against the infection, and clinical signs of fever, dry cough, and loss of taste or smell were associated with testing positive (p <0.05). A descriptive analysis of the indicators revealed that the entire population was susceptible to the disease. Intensified vaccination strategies are required regardless of socioeconomic factors, health conditions, and preventive measures. Implementation of objective, comprehensive, and efficient management tools to minimize the spread of COVID-19 in this municipality can serve as a model for other regions of Brazil.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Phylogenetic analysis of SARS-CoV-2 genome sequences in Araguaína, Brazil.
(A) Root-to-tip regression of genetic distances and sampling dates for the 1,875 SARS-CoV-2 genomes (R2 = 0.69; correlation coefficient = 0.83). (B) Time-resolved maximum-likelihood tree of 1,875 SARS-CoV-2 genomes. Tips are colored according to the PANGO lineages and red diamonds represent Araguaína genomes.

References

    1. BRASIL. Painel do Coronavírus Óbitos confirmados. In: Ministério da Saúde [Internet]. 2023 [cited 26 Mar 2023]. https://covid.saude.gov.br/
    1. Alhamid G, Tombuloglu H, Rabaan AA, Al-Suhaimi E. SARS-CoV-2 detection methods: A comprehensive review. Saudi Journal of Biological Sciences. Elsevier B.V.; 2022. doi: 10.1016/j.sjbs.2022.103465 - DOI - PMC - PubMed
    1. Reynard C, Allen JA, Shinkins B, Prestwich G, Goves J, Davies K, et al.. COVID-19 rapid diagnostics: practice review. Emerg Med J. 2022;39: 70–76. doi: 10.1136/emermed-2021-211814 - DOI - PMC - PubMed
    1. Dias NLC, Faccini-Martínez ÁA, Oliveira S. Análise das internações e da mortalidade por doenças febris, infecciosas e parasitárias durante a pandemia da COVID-19 no Brasil. InterAmerican Journal of Medicine and Health. 2020;4. doi: 10.31005/iajmh.v4i.173 - DOI
    1. Lam S, Lombardi A, Ouanounou A. COVID-19: A review of the proposed pharmacological treatments. Eur J Pharmacol. 2020;886. doi: 10.1016/j.ejphar.2020.173451 - DOI - PMC - PubMed